Strategies to treat Zika virus (ZIKV) infection in dengue virus (DENV) endemic areas are urgently needed. Here we show that a DENV-specific antibody against the E-dimer epitope (EDE) potent ly cross-neutralizes ZIKV and provides robust therapeutic efficacy as well as prophylactic efficacy against ZIKV in rhesus monkeys. Viral escape was not detected, suggesting a relatively high bar to escape. These data demonstrate the potential for antibody-based therapy and prevention of ZIKV
Zika virus (ZIKV), a mosquito-borne flavivirus with homology to Dengue virus (DENV), has become a pu...
International audienceThe four serotypes of dengue virus (DENV-1 to-4) cause the most important emer...
Studies have demonstrated cross-reactivity of anti-dengue virus (DENV) antibodies in human sera agai...
Strategies to treat Zika virus (ZIKV) infection in dengue virus (DENV)-endemic areas are urgently ne...
The Zika virus (ZIKV) epidemic has resulted in congenital abnormalities in fetuses and neonates. Alt...
Summary: Zika virus (ZIKV) causes severe neurologic complications and fetal aberrations. Vaccine dev...
ABSTRACT Zika virus (ZIKV) is a mosquito-borne flavivirus responsible for thousands of cases of seve...
Abstract Background Dengue Virus (DENV) and Zika Virus (ZIKV) are closely related flaviviruses, circ...
Despite numerous efforts to identify the molecular and cellular effectors of the adaptive immunity t...
Zika virus (ZIKV) causes severe neurologic complications and fetal aberrations. Vaccine development ...
Zika virus (ZIKV) was discovered in 1947 and was thought to lead to relatively mild disease. The rec...
Pre-existing immunity to flaviviruses can influence the outcome of subsequent flavivirus infections....
Zika virus (ZIKV), a mosquito-borne flavivirus with homology to Dengue virus (DENV), has become a pu...
International audienceThe four serotypes of dengue virus (DENV-1 to-4) cause the most important emer...
Studies have demonstrated cross-reactivity of anti-dengue virus (DENV) antibodies in human sera agai...
Strategies to treat Zika virus (ZIKV) infection in dengue virus (DENV)-endemic areas are urgently ne...
The Zika virus (ZIKV) epidemic has resulted in congenital abnormalities in fetuses and neonates. Alt...
Summary: Zika virus (ZIKV) causes severe neurologic complications and fetal aberrations. Vaccine dev...
ABSTRACT Zika virus (ZIKV) is a mosquito-borne flavivirus responsible for thousands of cases of seve...
Abstract Background Dengue Virus (DENV) and Zika Virus (ZIKV) are closely related flaviviruses, circ...
Despite numerous efforts to identify the molecular and cellular effectors of the adaptive immunity t...
Zika virus (ZIKV) causes severe neurologic complications and fetal aberrations. Vaccine development ...
Zika virus (ZIKV) was discovered in 1947 and was thought to lead to relatively mild disease. The rec...
Pre-existing immunity to flaviviruses can influence the outcome of subsequent flavivirus infections....
Zika virus (ZIKV), a mosquito-borne flavivirus with homology to Dengue virus (DENV), has become a pu...
International audienceThe four serotypes of dengue virus (DENV-1 to-4) cause the most important emer...
Studies have demonstrated cross-reactivity of anti-dengue virus (DENV) antibodies in human sera agai...